Company page
Precision Biosciences, Inc.
Precision Biosciences, Inc. is a public company traded under the ticker DTIL in the American market. The company has a market capitalization of approximately $157.4 million. Precision Biosciences focuses on developing innovative gene editing technologies for therapeutic applications.
- Ticker
- DTIL:NASDAQ
- Asset type
- Stock
- Market cap
- $157.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD